Currently out of the existing stock ratings of Michael Sarcone, 6 are a HOLD (27.27%), 16 are a BUY (72.73%).

Michael Sarcone

Work Performance Price Targets & Ratings Chart

Analyst Michael Sarcone, currently employed at JEFFERIES, has had 80.21% of price targets met with an average potential upside of 15.77%, reached in 81 days on average.

Michael Sarcone has documented 44 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GKOS, Glaukos Corp at 21-Sep-2026.

Wall Street Analyst Michael Sarcone

Analyst best performing recommendations are on PROF.
The best stock recommendation documented was for EDAP on 4/4/2025. The price target of $2 was fulfilled within 21 days with a profit of $0.39 (24.22%), with a performance score of 11.54.

Average potential price target upside

AXGN Axogen EDAP INSP PRCT Procept Biorobotics Corp XRAY Dentsply Sirona ALGN Align Technology GKOS Glaukos Corp PROF BCOR Blucora

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Aug-2026

$60

$4.07 (7.28%)

$53

20 days ago
(29-Oct-2026)

1/3 (33.33%)

$10.37 (20.89%)

41

Buy Since 19-Feb-2026

$56

$0.07 (0.13%)

$48

20 days ago
(29-Oct-2026)

3/3 (100%)

$6.37 (12.83%)

62

Buy Since 16-Oct-2023

$56

$0.07 (0.13%)

$25

20 days ago
(29-Oct-2026)

3/3 (100%)

$6.37 (12.83%)

126

Buy Since 30-Sep-2025

$56

$0.07 (0.13%)

$53

20 days ago
(29-Oct-2026)

6/6 (100%)

$6.37 (12.83%)

74

Buy Since 30-Oct-2018

$52

$-3.93 (-7.03%)

$19

1 months 6 days ago
(12-Oct-2026)

7/7 (100%)

$15.87 (43.92%)

1241

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Sarcone most bullish on?

Potential upside of $-34.88 has been obtained for GKOS (GLAUKOS CORP)

What Year was the first public recommendation made by Michael Sarcone?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?